Home » Topics » Conferences

Conferences
RSS

Semisynthetic pneumocandin analogue for fungal infections

Oct. 4, 1996

PathoGenesis selects nitroimidazopyran as potential tuberculosis Rx

Oct. 4, 1996

IntraBiotics' protegrins as potential treatments for multi-drug-resistant infections & gastric ulcer

Oct. 4, 1996

Potential antitubercular agents from PathoGenesis

Oct. 4, 1996

Another series of multifunctional antibacterial agents from P&G

Oct. 4, 1996

Quinolonyl-carbapenems from P&G

Oct. 4, 1996

Orally active ester-type carbapenem prodrug from Sankyo

Oct. 4, 1996

Novel carbapenem with anti-MRSA activity from Banyu

Oct. 4, 1996

Carbapenem from Merck & Co. undergoing extensive evaluation

Oct. 4, 1996

P&G describes quinolonyl-cephem dithiocarbamates

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...